Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

NCT04668950 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

670

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Coronavirus

Interventions

DRUG: Fluvoxamine
DRUG: Placebo

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]